Stay updated on OPTIM Study: Immunotherapy in Head and Neck Clinical Trial
Sign up to get notified when there's something new on the OPTIM Study: Immunotherapy in Head and Neck Clinical Trial page.

Latest updates to the OPTIM Study: Immunotherapy in Head and Neck Clinical Trial page
- Check4 days agoChange DetectedThe page shows a minor revision from v3.3.3 to v3.3.4 with no visible changes to study details or contents. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedFooter updates include the addition of Revision: v3.3.3 and removal of HHS Vulnerability Disclosure and Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision history shows an update from v3.2.0 to v3.3.2; this is a minor maintenance change and does not modify study content, eligibility criteria, outcomes, or other user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check61 days agoChange DetectedThe government funding status notice was removed from the page. The study details and related information remain unchanged.SummaryDifference0.4%

- Check69 days agoChange DetectedTwo screenshots show no significant additions or deletions; the page content and layout appear unchanged.SummaryDifference0.5%

- Check104 days agoChange DetectedMajor update: new government funding/operating status notice and v3.2.0 version; minor removal of a specific resource (Squamous cell carcinoma of the head and neck) and removal of the old v3.1.0 tag.SummaryDifference4%

Stay in the know with updates to OPTIM Study: Immunotherapy in Head and Neck Clinical Trial
Enter your email address, and we'll notify you when there's something new on the OPTIM Study: Immunotherapy in Head and Neck Clinical Trial page.